Across-Country Variations of Real-World Data and Evidence for Drugs: A 5-European-Country Study
de Pouvourville G, Cunningham D, Fricke FU, Lindgren P, Mantovani L, Murphy LA, Solà-Morales O, Mestre-Ferrandiz J, Akehurst R
Using a combination of desk research and expert opinion collated by country experts in England, France, Germany, Italy, and Sweden, this article aimed to provide the reader with an understanding of the use of real-world evidence for health technology assessment and reimbursement decisions in each geography.
The article also helps identify key issues shared across the countries and identify areas of improvement that might reduce skepticism and promote more efficient use of real-world evidence.
Value in Health, 2023 Jan 26:S1098-3015(23)00015-3